×
Customize
?
Start
Cancer Types
Quick Links
Events
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Vulvar Cancer
Katie Kosko
A patient turned advocate underscores the importance of education, especially for those facing a rare cancer.
Katie Kosko and Brielle Benyon
We've got a sneak peek at what’s inside CURE®'s Women’s Cancers issue.
Katie Kosko
Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.
Brielle Urciuoli
The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.
Kristie L. Kahl
The application is seeking approval for GARDASIL 9 to be used in women and men aged 27 to 45 years for the prevention of certain cancers and diseases caused by the nine human papillomavirus (HPV) types covered by the vaccine.
Katie Kosko
Women with vulvar cancer who test positive for human papillomavirus (HPV) may have improved survival compared with HPV-negative patients, according to the results of a new study.
Jason Harris
Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.
Wayne Kuznar
Treatment changes for the rare illness include less invasive surgery.
Christina Izzo
A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.
Beth Fand Incollingo
States with the highest incidence of, and mortality from, cervical cancer also have the lowest uptake of the human papillomavirus (HPV) vaccine by adolescent girls, researchers found in a recent study.